Hypertension Diagnostics Price on February 8, 2023

HDIIDelisted Stock  USD 0  0.0008  38.10%   
If you're considering investing in Hypertension Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Hypertension Diagnostics stands at 0, as last reported on the 12th of December 2024, with the highest price reaching 0 and the lowest price hitting 0 during the day. We have found thirty technical indicators for Hypertension Diagnostics, which you can use to evaluate the volatility of the firm. Please check out Hypertension Diagnostics' Market Risk Adjusted Performance of (6.08), downside deviation of 18.77, and Risk Adjusted Performance of 0.0321 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Hypertension Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
HDII
Based on monthly moving average Hypertension Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hypertension Diagnostics by adding Hypertension Diagnostics to a well-diversified portfolio.

Hypertension Diagnostics Valuation on February 8, 2023

It is possible to determine the worth of Hypertension Diagnostics on a given historical date. On February 8, 2023 Hypertension was worth 0.0021 at the beginning of the trading date compared to the closed value of 0.0029. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Hypertension Diagnostics pink sheet. Still, in general, we apply an absolute valuation method to find Hypertension Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Hypertension Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Hypertension Diagnostics' related companies.
 Open High Low Close Volume
  0    0    0    0    92,775  
02/08/2023
  0    0    0    0    14,000  
  0    0    0    0    0.00  
Backtest Hypertension Diagnostics  |  Hypertension Diagnostics History  |  Hypertension Diagnostics Valuation   PreviousNext  
Open Value
0.0021
0.0029
Closing Value
0.00
Upside

Hypertension Diagnostics Trading Date Momentum on February 8, 2023

On December 12 2024 Hypertension Diagnostics was traded for  0  at the closing time. The top price for the day was 0  and the lowest listed price was  0 . There was no trading activity during the period 0.0. Lack of trading volume on December 12, 2024 did not cause price change. The trading delta at closing time against the current closing price is 27.59% .

Hypertension Diagnostics Fundamentals Correlations and Trends

By evaluating Hypertension Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Hypertension Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Hypertension financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Hypertension Diagnostics Pink Sheet history

Hypertension Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Hypertension is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Hypertension Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Hypertension Diagnostics stock prices may prove useful in developing a viable investing in Hypertension Diagnostics
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada. Hypertension Diag operates under Shell Companies classification in the United States and is traded on OTC Exchange.

Hypertension Diagnostics Pink Sheet Technical Analysis

Hypertension Diagnostics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Hypertension Diagnostics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Hypertension Diagnostics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Hypertension Diagnostics Period Price Range

Low
December 12, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Hypertension Diagnostics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Hypertension Diagnostics December 12, 2024 Market Strength

Market strength indicators help investors to evaluate how Hypertension Diagnostics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hypertension Diagnostics shares will generate the highest return on investment. By undertsting and applying Hypertension Diagnostics pink sheet market strength indicators, traders can identify Hypertension Diagnostics entry and exit signals to maximize returns

Hypertension Diagnostics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Hypertension Diagnostics' price direction in advance. Along with the technical and fundamental analysis of Hypertension Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Hypertension to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in Hypertension Pink Sheet

If you are still planning to invest in Hypertension Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hypertension Diagnostics' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk